May 20, 2020 / 07:05PM GMT
Greg Renza - RBC Capital Markets - VP, Equity Research Analyst
Good afternoon everyone and welcome back to the 2020 RBC Capital Markets Virtual Healthcare Conference. My name is Greg Renza, one of the RBC equity research analysts in biotechnology and I'm pleased to have with us today Equillium, represented by chief executive officer, Bruce Steel; and chief medical officer, Dr. Krishna Polu. Gentlemen, thanks for joining us.
Bruce Steel - Equillium, Inc. - CEO
Greg, thank you very much. It's a pleasure to be here today with you all virtually. Everybody attending is [involved] in the face of the ongoing COVID pandemic. I know this is a challenging time for everybody but where you may be we hope you're safe and sound and weathering the storm as it's challenging for everybody.
Greg Renza - RBC Capital Markets - VP, Equity Research Analyst
Thanks, Bruce. We all appreciate the comments there. And Bruce, let's dive right in. For those of us who aren't as familiar with the Equillium story, let's give you the opportunity to
Equillium Inc at RBC Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
